Abstract |
We recently reported that intraperitoneal administration of leptin-related synthetic peptide 116-130 [LEP-(116-130)] resulted in reduced food intake and significant weight loss in homozygous female C57BL/6J ob/ob mice. In this study, we used two in vitro bioassays to show that the interaction of LEP-(116-130) with the long form of the leptin receptor (OB-Rb), the receptor isoform that is predominantly expressed in the hypothalamus, is not required for the observed in vivo effects of the peptide on energy balance. LEP-(116-130) was unable to compete the binding of alkaline phosphatase- leptin fusion protein to OB-R. Moreover, LEP-(116-130) was unable to activate signal transduction by OB-Rb in vitro. In homozygous female C57BLKS/J-m db/db mice that do not express OB-Rb, intraperitoneal administration of LEP-(116-130) reduced body weight gain and blood glucose levels but not food intake, which further supports a mechanism of action that does not require peptide interaction with OB-Rb.
|
Authors | P Grasso, D W White, L A Tartaglia, M C Leinung, D W Lee |
Journal | Diabetes
(Diabetes)
Vol. 48
Issue 11
Pg. 2204-9
(Nov 1999)
ISSN: 0012-1797 [Print] United States |
PMID | 10535455
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Blood Glucose
- Carrier Proteins
- Leptin
- Ligands
- Peptide Fragments
- Receptors, Cell Surface
- Receptors, Leptin
- Recombinant Proteins
- leptin receptor, mouse
|
Topics |
- Animals
- Blood Glucose
(drug effects, metabolism)
- Body Temperature Regulation
(drug effects)
- COS Cells
- Carrier Proteins
(drug effects, genetics, physiology)
- Cell Line
- Feeding Behavior
(drug effects, physiology)
- Female
- Homozygote
- Hypothalamus
(physiology)
- Leptin
(pharmacology)
- Ligands
- Mice
- Mice, Inbred C57BL
- Mice, Obese
- Peptide Fragments
(pharmacology)
- Receptors, Cell Surface
- Receptors, Leptin
- Recombinant Proteins
(drug effects, metabolism)
- Transfection
- Weight Gain
(drug effects, physiology)
|